Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANXA2R overlapping transcript 1 (ANXA2R-OT1) is a human long non-coding RNA (lncRNA) gene, defined as a genomic transcript that overlaps the protein-coding region of the ANXA2R gene on the same strand[2][3]. According to the HUGO Gene Nomenclature Committee, overlapping transcripts in this context are specifically lncRNAs, which do not encode proteins and whose molecular and biological roles are often poorly characterized[2]. The ANXA2R-OT1 gene is affiliated with the lncRNA class and has been associated in the literature or by database annotation with descending colon cancer[3]. However, no data currently support any receptor, enzyme, or transporter activity, and there is no evidence it is a direct therapeutic target or interacts with drugs. Furthermore, it is important to distinguish this lncRNA from the nearby protein-coding gene ANXA2R or ANXA2 for which functional receptor or protein data may be available[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANXA2R overlapping transcript 1 (ANXA2R-OT1).